The clinical investigation of psychedelic medicines has blossomed over the last 5 years.
Data from a Phase 3 industry trial and a multicenter Phase 2 industry trial, in addition to …

The therapeutic potential of the psychedelic brew ayahuasca has been investigated in
preclinical and clinical studies. Currently, the most consistent evidence refers to depression …

Introduction Ayahuasca is a plant-based decoction native to Amazonia, where it has a long
history of use in traditional medicine. Contemporary ritual use of ayahuasca has been …

Rationale Studies have suggested mental health improvements following the use of the
psychotropic plant concoction ayahuasca in non-clinical and clinical samples. Objectives …

Psychedelics or serotonergic hallucinogens are a group of substances that share the
agonism of serotonergic 5-HT2A receptors as their main mechanism of action. Its main …

Microdosing psychedelic drugs—that is, taking sub-behavioral doses of lysergic acid
diethylamide (LSD) or psilocybin—is a growing practice in Western societies. Taken mainly …

Background: Naturalistic and placebo-controlled studies have suggested that ayahuasca, a
traditional Amazonian beverage, could be helpful in the treatment of psychopathologies like …

Objective Reports have indicated possible uses of ayahuasca for the treatment of conditions
including depression, addictions, post‐traumatic stress disorder, anxiety and specific …

Ayahuasca is a natural psychoactive brew, used in traditional ceremonies in the Amazon
basin. Recent research has indicated that ayahuasca is pharmacologically safe and its use …

Promoting well-being is one of the main goals to improve health in the world. We examined
the well-being and quality of life over the course of one year in a sample that participated in …